Intellicheck Announces Third Quarter 2022 Financial Results
Intellicheck, Inc. (Nasdaq: IDN) reported a 22% growth in SaaS revenue for Q3 2022, totaling $4 million despite a decline in overall revenue compared to last year. The company's core SaaS revenue reached $3.97 million, up from $3.25 million in Q3 2021. Gross profit margin improved to 91% versus 69% in the prior year. Adjusted EBITDA showed positive results at $75,000, compared to a loss of $272,000 in 2021. Although the company reported a net loss of $724,000 for the quarter, they highlighted growth in customer base and technology solutions.
- SaaS revenue increased 22% to $3.97 million.
- Gross profit margin rose to 91% from 69% year-over-year.
- Achieved positive Adjusted EBITDA of $75,000 compared to a loss of $272,000 in 2021.
- Total revenue dropped to $4.01 million from $4.83 million year-over-year.
- Net loss of $724,000, though improved from a $1,026,000 loss in Q3 2021.
Record SaaS Revenue Grew
Company Achieved Adjusted EBITDA Positive Results
“New products and use cases, including expanded digital applications, and the growth of our customer base continues to drive increased revenues and transaction volume. We are proud of our success in providing customers and partners with the leading-edge technology and frictionless customer experience that delivers solutions to the challenges of physical and digital identity validation with near perfect certainty. We believe these important strides are just the beginning as we remain focused on providing our clients with best-in-class, adaptable technology solutions. We are setting the stage for what we believe will be even greater growth and innovation in the future,” said
Gross profit as a percentage of revenues was
Operating expenses for the three months ended
Net loss for the three months ended
Adjusted EBITDA (earnings before gains on debt forgiveness, other income, income taxes, depreciation, amortization, and equity compensation expense) was
As of
The financial results reported today do not consider any adjustments that may be required in connection with the completion of the Company’s review process and should be considered preliminary until
Conference Call Information
The Company will hold an earnings conference call on
A replay of the conference call will be available shortly after completion of the live event. To listen to the replay, please dial 877-660-6853 and use conference identification number 13726737. For callers outside the
|
|||||||
CONDENSED BALANCE SHEETS |
|||||||
(In thousands except share amounts) |
|||||||
|
|
|
|
||||
|
(Unaudited) |
|
|
||||
ASSETS |
|
|
|
||||
CURRENT ASSETS: |
|
|
|
||||
Cash and cash equivalents |
$ |
11,775 |
|
|
$ |
13,651 |
|
Accounts receivable, net of allowance of |
|
2,635 |
|
|
|
2,192 |
|
Other current assets |
|
467 |
|
|
|
643 |
|
Total current assets |
|
14,877 |
|
|
|
16,486 |
|
|
|
|
|
||||
PROPERTY AND EQUIPMENT, net |
|
772 |
|
|
|
737 |
|
|
|
8,102 |
|
|
|
8,102 |
|
INTANGIBLE ASSETS, net |
|
299 |
|
|
|
378 |
|
OTHER ASSETS |
|
8 |
|
|
|
8 |
|
Total assets |
$ |
24,058 |
|
|
$ |
25,711 |
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
||||
|
|
|
|
||||
CURRENT LIABILITIES: |
|
|
|
||||
Accounts payable |
$ |
614 |
|
|
$ |
368 |
|
Accrued expenses |
|
2,036 |
|
|
|
2,870 |
|
Equity awards liability |
|
100 |
|
|
|
378 |
|
Liability for shares withheld |
|
1,244 |
|
|
|
1,244 |
|
Deferred revenue, current portion |
|
1,730 |
|
|
|
1,266 |
|
Total current liabilities |
|
5,724 |
|
|
|
6,126 |
|
|
|
|
|
||||
OTHER LIABILITIES: |
|
|
|
||||
Deferred revenue, long-term portion |
|
2 |
|
|
|
8 |
|
Total liabilities |
|
5,726 |
|
|
|
6,134 |
|
|
|
|
|
||||
COMMITMENTS AND CONTINGENCIES (Note 9) |
|
|
|
||||
|
|
|
|
||||
STOCKHOLDERS’ EQUITY: |
|
|
|
||||
Common stock - |
|
19 |
|
|
|
19 |
|
Additional paid-in capital |
|
148,500 |
|
|
|
146,455 |
|
Accumulated deficit |
|
(130,187 |
) |
|
|
(126,897 |
) |
Total stockholders’ equity |
|
18,332 |
|
|
|
19,577 |
|
|
|
|
|
||||
Total liabilities and stockholders’ equity |
$ |
24,058 |
|
|
$ |
25,711 |
|
|
|||||||||||||||
CONDENSED STATEMENTS OF OPERATIONS |
|||||||||||||||
(In thousands except shares and per share amounts) |
|||||||||||||||
(Unaudited) |
|||||||||||||||
|
Three months ended |
|
Nine months ended |
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
|
|
|
|
|
|
|
|
||||||||
REVENUES |
$ |
4,012 |
|
|
$ |
4,831 |
|
|
$ |
11,415 |
|
|
$ |
12,491 |
|
COST OF REVENUES |
|
(358 |
) |
|
|
(1,510 |
) |
|
|
(1,038 |
) |
|
|
(3,200 |
) |
Gross profit |
|
3,654 |
|
|
|
3,321 |
|
|
|
10,377 |
|
|
|
9,291 |
|
|
|
|
|
|
|
|
|
||||||||
OPERATING EXPENSES |
|
|
|
|
|
|
|
||||||||
Selling, general and administrative |
|
2,917 |
|
|
|
2,930 |
|
|
|
8,985 |
|
|
|
11,688 |
|
Research and development |
|
1,461 |
|
|
|
1,416 |
|
|
|
4,682 |
|
|
|
4,105 |
|
Total operating expenses |
|
4,378 |
|
|
|
4,346 |
|
|
|
13,667 |
|
|
|
15,793 |
|
|
|
|
|
|
|
|
|
||||||||
Loss from operations |
|
(724 |
) |
|
|
(1,025 |
) |
|
|
(3,290 |
) |
|
|
(6,502 |
) |
|
|
|
|
|
|
|
|
||||||||
OTHER INCOME |
|
|
|
|
|
|
|
||||||||
Gain on forgiveness of unsecured promissory note |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
10 |
|
Interest and other income |
|
— |
|
|
|
(1 |
) |
|
|
— |
|
|
|
6 |
|
Total other income |
|
— |
|
|
|
(1 |
) |
|
|
— |
|
|
|
16 |
|
|
|
|
|
|
|
|
|
||||||||
Net loss |
$ |
(724 |
) |
|
$ |
(1,026 |
) |
|
$ |
(3,290 |
) |
|
$ |
(6,486 |
) |
|
|
|
|
|
|
|
|
||||||||
PER SHARE INFORMATION |
|
|
|
|
|
|
|
||||||||
Loss per common share - |
|
|
|
|
|
|
|
||||||||
Basic/Diluted |
$ |
(0.04 |
) |
|
$ |
(0.06 |
) |
|
$ |
(0.17 |
) |
|
$ |
(0.35 |
) |
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares used in computing per share amounts - |
|
|
|
|
|
|
|
||||||||
Basic/Diluted |
|
18,918,596 |
|
|
|
18,642,463 |
|
|
|
18,802,892 |
|
|
18,580,012 |
|
|||||||||||||||
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY |
|||||||||||||||
(In thousands except number of shares) |
|||||||||||||||
(Unaudited) |
|||||||||||||||
|
Three months ended |
||||||||||||||
|
Common Stock |
|
Additional
|
|
Accumulated
|
|
Total
|
||||||||
|
Shares |
|
Amount |
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||
BALANCE, |
18,875,580 |
|
$ |
19 |
|
$ |
147,804 |
|
$ |
(129,463 |
) |
|
$ |
18,360 |
|
|
|
|
|
|
|
|
|
|
|
||||||
Stock-based compensation |
— |
|
|
— |
|
|
663 |
|
|
— |
|
|
|
663 |
|
Change in fair value of Equity awards liabilities |
– |
|
|
– |
|
|
33 |
|
|
– |
|
|
|
33 |
|
Issuance of shares for vested restricted stock grants |
54,932 |
|
|
— |
|
|
— |
|
|
— |
|
|
|
— |
|
Net loss |
— |
|
|
— |
|
|
— |
|
|
(724 |
) |
|
|
(724 |
) |
BALANCE, |
18,930,512 |
|
$ |
19 |
|
$ |
148,500 |
|
$ |
(130,187 |
) |
|
$ |
18,332 |
|
|
Three months ended |
||||||||||||||
|
Common Stock |
|
Additional
|
|
Accumulated
|
|
Total
|
||||||||
|
Shares |
|
Amount |
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||
BALANCE, |
18,634,918 |
|
$ |
19 |
|
$ |
145,018 |
|
$ |
(124,879 |
) |
|
$ |
20,158 |
|
|
|
|
|
|
|
|
|
|
|
||||||
Stock-based compensation |
— |
|
|
— |
|
|
639 |
|
|
— |
|
|
|
639 |
|
Issuance of shares for vested restricted stock grants |
8,363 |
|
|
— |
|
|
— |
|
|
— |
|
|
|
— |
|
Net loss |
— |
|
|
— |
|
|
— |
|
|
(1,026 |
) |
|
|
(1,026 |
) |
BALANCE, |
18,643,281 |
|
$ |
19 |
|
$ |
145,657 |
|
$ |
(125,905 |
) |
|
$ |
19,771 |
|
|
|||||||||||||||
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY |
|||||||||||||||
(In thousands except number of shares) |
|||||||||||||||
(Unaudited) |
|||||||||||||||
|
Nine months ended |
||||||||||||||
|
Common Stock |
|
Additional
|
|
Accumulated |
|
Total
|
||||||||
|
Shares |
|
Amount |
|
Capital |
|
Deficit |
|
Equity |
||||||
|
|
|
|
|
|
|
|
|
|
||||||
BALANCE, |
18,660,369 |
|
$ |
19 |
|
$ |
146,455 |
|
$ |
(126,897 |
) |
|
$ |
19,577 |
|
|
|
|
|
|
|
|
|
|
|
||||||
Stock-based compensation |
— |
|
|
— |
|
|
1,768 |
|
|
— |
|
|
|
1,768 |
|
Change in fair value of Equity awards liabilities |
– |
|
|
– |
|
|
277 |
|
|
– |
|
|
|
277 |
|
Issuance of shares for vested restricted stock grants |
270,143 |
|
|
— |
|
|
— |
|
|
— |
|
|
|
— |
|
Net loss |
— |
|
|
— |
|
|
— |
|
|
(3,290 |
) |
|
|
(3,290 |
) |
BALANCE, |
18,930,512 |
|
$ |
19 |
|
$ |
148,500 |
|
$ |
(130,187 |
) |
|
$ |
18,332 |
|
|
Nine months ended |
||||||||||||||
|
Common Stock |
|
Additional
|
|
Accumulated |
|
Total
|
||||||||
|
Shares |
|
Amount |
|
Capital |
|
Deficit |
|
Equity |
||||||
|
|
|
|
|
|
|
|
|
|
||||||
BALANCE, |
18,410,458 |
|
$ |
18 |
|
$ |
141,612 |
|
$ |
(119,419 |
) |
|
$ |
22,211 |
|
|
|
|
|
|
|
|
|
|
|
||||||
Stock-based compensation |
— |
|
|
— |
|
|
2,270 |
|
|
— |
|
|
|
2,270 |
|
Exercise of stock options, net of cashless exercise of 58,122 shares and 92,634 shares withheld |
206,545 |
|
|
1 |
|
|
1,755 |
|
|
— |
|
|
|
1,756 |
|
Exercise of warrants |
9,000 |
|
|
— |
|
|
20 |
|
|
— |
|
|
|
20 |
|
Issuance of shares for vested restricted stock grants |
17,278 |
|
|
— |
|
|
— |
|
|
— |
|
|
|
— |
|
Net loss |
— |
|
|
— |
|
|
— |
|
|
(6,486 |
) |
|
|
(6,486 |
) |
BALANCE, |
18,643,281 |
|
$ |
19 |
|
$ |
145,657 |
|
$ |
(125,905 |
) |
|
$ |
19,771 |
|
CONDENSED STATEMENTS OF CASH FLOWS |
|||||||
(In thousands) |
|||||||
(Unaudited) |
|||||||
|
Nine months ended |
||||||
|
2022 |
|
2021 |
||||
|
|
|
|
||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
||||
Net loss |
$ |
(3,290 |
) |
|
$ |
(6,486 |
) |
Adjustments to reconcile net loss to net cash (used in) provided by |
|
|
|
||||
operating activities |
|
|
|
||||
Depreciation and amortization |
|
209 |
|
|
|
126 |
|
Stock-based compensation |
|
1,768 |
|
|
|
6,006 |
|
Bad debt expense |
|
(9 |
) |
|
|
(3 |
) |
Forgiveness of unsecured promissory note |
|
— |
|
|
|
(10 |
) |
Changes in assets and liabilities: |
|
|
|
||||
Increase in accounts receivable |
|
(434 |
) |
|
|
(654 |
) |
Decrease (increase) in other current assets and long-term assets |
|
176 |
|
|
|
(534 |
) |
(Decrease) increase in accounts payable and accrued expenses |
|
(588 |
) |
|
|
991 |
|
Increase in deferred revenue |
|
457 |
|
|
|
971 |
|
Net cash (used in) provided by operating activities |
|
(1,711 |
) |
|
|
407 |
|
|
|
|
|
||||
|
|
|
|
||||
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
||||
Purchases of property and equipment |
|
(165 |
) |
|
|
(339 |
) |
Net cash used in investing activities |
|
(165 |
) |
|
|
(339 |
) |
|
|
|
|
||||
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
||||
Return of repayment on unsecured promissory note |
|
— |
|
|
|
10 |
|
Net proceeds from issuance of common stock from exercise of stock options |
|
— |
|
|
|
46 |
|
Proceeds from issuance of common stock from exercise of warrants |
|
— |
|
|
|
20 |
|
Net cash provided by financing activities |
|
— |
|
|
|
76 |
|
|
|
|
|
||||
Net (decrease) increase in cash |
|
(1,876 |
) |
|
|
145 |
|
|
|
|
|
||||
CASH, beginning of period |
|
13,651 |
|
|
|
13,121 |
|
|
|
|
|
||||
CASH, end of period |
$ |
11,775 |
|
|
$ |
13,266 |
|
|
|
|
|
||||
Supplemental disclosure of noncash investing and financing activities: |
|
|
|
||||
Reclassification of stock option awards |
$ |
— |
|
|
$ |
1,411 |
|
Adjusted EBITDA and Use of a Non-GAAP Measure
We use Adjusted EBITDA as a non-GAAP financial performance measurement. Adjusted EBITDA is calculated by adjusting net loss for certain items such gains on debt forgiveness and other income and certain addbacks such as income taxes, depreciation, amortization, and stock-based compensation expenses. Adjusted EBITDA is provided to investors to supplement the results of operations reported in accordance with GAAP. Management believes that Adjusted EBITDA provides an additional tool for investors to use in comparing our financial results with other companies that also use Adjusted EBITDA in their communications to investors. By excluding non-cash charges such as impairments of long-lived assets and goodwill, amortization, depreciation, and stock-based compensation, as well as non-operating charges for interest and income taxes, investors can evaluate our operations and can compare the results on a more consistent basis to the results of other companies. In addition, Adjusted EBITDA is one of the primary measures management uses to monitor and evaluate financial and operating results.
We consider Adjusted EBITDA to be an important indicator of our operational strength and performance of our business and a useful measure of our historical operating trends. However, there are significant limitations to the use of Adjusted EBITDA since it excludes gains on debt forgiveness, other income, impairments of long-lived assets and goodwill, and stock-based compensation, all of which impact our profitability, as well as depreciation and amortization related to the use of long-term assets which benefit multiple periods. We believe that these limitations are compensated by providing Adjusted EBITDA only with GAAP net loss and clearly identifying the difference between the two measures. Consequently, Adjusted EBITDA should not be considered in isolation or as a substitute for net loss presented in accordance with GAAP. Adjusted EBITDA as defined by us may not be comparable with similarly named measures provided by other entities.
A reconciliation of GAAP net loss to Non-GAAP Adjusted EBITDA follows:
|
(Unaudited) |
||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Net loss |
$ |
(724 |
) |
|
$ |
(1,026 |
) |
|
$ |
(3,290 |
) |
|
$ |
(6,486 |
) |
Reconciling items: |
|
|
|
|
|
|
|
||||||||
Gain on forgiveness of unsecured promissory note |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(10 |
) |
Interest and other income |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(5 |
) |
Depreciation and amortization |
|
70 |
|
|
|
42 |
|
|
|
209 |
|
|
|
126 |
|
Stock-based compensation including liability classified awards |
|
729 |
|
|
|
712 |
|
|
|
1,768 |
|
|
|
6,006 |
|
Adjusted EBITDA |
$ |
75 |
|
|
$ |
(272 |
) |
|
$ |
(1,313 |
) |
|
$ |
(369 |
) |
About
Safe Harbor Statement
Statements in this news release about Intellicheck’s future expectations, including: the advantages of our products, future demand for Intellicheck’s existing and future products, whether revenue and other financial metrics will improve in future periods, whether
View source version on businesswire.com: https://www.businesswire.com/news/home/20221114005623/en/
Investor Relations:
Media and Public Relations:
Source:
FAQ
What were Intellicheck's earnings results for Q3 2022?
What is the growth rate of Intellicheck's SaaS revenue?
What is Intellicheck's Adjusted EBITDA for Q3 2022?